Brainstorm cell therapeutics to present at european life sciences ceo forum

New york , feb. 13, 2024 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that it will provide a corporate update at the 17th annual european life sciences ceo forum to take place 28 - 29 of february, 2024 in zurich, switzerland. presentation details presentation date: wednesday, 28th februarytime: 13:40h cetlocation: panorama room (track c), hilton zurich airport hotel dr. stacy lindborg, co-ceo of brainstorm, will also participate in a panel discussion neuro advances panel: highlighting the main opportunities, at 17:20h on february 28.
BCLI Ratings Summary
BCLI Quant Ranking